Enlivex announces allowance of new japanese patent application covering allocetra immunotherapy

Nes-ziona, israel, june 18, 2020 (globe newswire) -- enlivex therapeutics, ltd., a clinical-stage immunotherapy company, today announced that the japan patent office (jpo) has issued a notice of allowance for a patent application covering allocetratm, the company’s immunotherapy product candidate.  upon issuance, the new patent will provide additional intellectual property protection around methods of using allocetratm and pharmaceutical compositions comprising the same. the company expects the new patent to issue in japan during the third quarter of 2020.
ENLV Ratings Summary
ENLV Quant Ranking